bendamustine hydrochloride has been researched along with Opportunistic Infections in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abi Hatem, N; Dameron, M; Gupta, N; Horowitz, M | 1 |
| Iwasaki, H; Kadowaki, M; Kohno, K; Takase, K; Yamasaki, S | 1 |
| Kawashima, I; Kirito, K; Mitsumori, T; Nakajima, K; Nozaki, Y; Sueki, Y; Yamamoto, T | 1 |
| Izutsu, K; Maruyama, D; Nisikori, M; Ohmachi, K; Suzuki, T | 1 |
| Fiegl, M; Gastl, G; Hager, J; Oexle, H; Schnallinger, M; Schreieck, S; Stauder, R; Verdorfer, I; Waldthaler, C; Zabernigg, A; Zangerl, G | 1 |
| Heymanns, J; Köppler, H; Pandorf, A; Weide, R | 1 |
2 review(s) available for bendamustine hydrochloride and Opportunistic Infections
| Article | Year |
|---|---|
[Development of cytomegalovirus antigenemia in 3 patients with B cell lymphoma treated with bendamustine monotherapy].
Topics: Adult; Aged; Antigens, Viral; Antiviral Agents; Bendamustine Hydrochloride; Biomarkers; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Lymphoma, B-Cell; Male; Middle Aged; Nitrogen Mustard Compounds; Opportunistic Infections; Treatment Outcome; Valganciclovir; Virus Activation | 2014 |
[Recommendation for the optimal use of bendamustine in Japan].
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Clinical Trials as Topic; Cytomegalovirus Infections; Drug Administration Schedule; Drug Eruptions; Evidence-Based Medicine; Hepatitis B; Humans; Immunocompromised Host; Japan; Lymphoma, B-Cell; Lymphoma, Mantle-Cell; Nausea; Nitrogen Mustard Compounds; Opportunistic Infections; Rituximab; Vasculitis | 2014 |
1 trial(s) available for bendamustine hydrochloride and Opportunistic Infections
| Article | Year |
|---|---|
Bendamustine plus mitoxantrone--a new effective treatment for advanced chronic lymphocytic leukaemia: results of a phase I/II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Mitoxantrone; Nitrogen Mustard Compounds; Opportunistic Infections; Remission Induction; Survival Analysis | 2004 |
3 other study(ies) available for bendamustine hydrochloride and Opportunistic Infections
| Article | Year |
|---|---|
When to consider Pneumocystis jirovecii prophylaxis in HIV-negative patients.
Topics: Aged; Anti-Bacterial Agents; Bendamustine Hydrochloride; HIV Seronegativity; Humans; Immunocompromised Host; Lung Diseases, Interstitial; Lymphoma, Mantle-Cell; Male; Opportunistic Infections; Pneumonia, Pneumocystis; Prednisone; Pulmonary Disease, Chronic Obstructive; Pulmonary Fibrosis; Rituximab; Trimethoprim, Sulfamethoxazole Drug Combination | 2021 |
Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine.
Topics: Academic Medical Centers; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Administration Schedule; Female; Follow-Up Studies; Ganciclovir; Humans; Injections, Intravenous; Intravitreal Injections; Japan; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Grading; Neoplasm Recurrence, Local; Opportunistic Infections; Retrospective Studies | 2017 |
Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Austria; Bendamustine Hydrochloride; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Nitrogen Mustard Compounds; Opportunistic Infections; Pancytopenia; Retrospective Studies; Rituximab; Treatment Outcome | 2011 |